Comment on: T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study
Author(s) -
P Lewis White,
Rosemary A. Barnes,
Rebecca Gorton,
Mario Cruciani,
Juergen Loeffler,
Alexandre Alanio,
Ralf Bialek,
Stéphane Bretagne,
Dieter Buchheidt,
Marı́a Serna,
Angie Caliendo,
Sharon Chen,
Neil T. Clancy,
Massimo Cogliati,
Catherine Cordonnier,
Brendan Crowley,
J. Peter Donnelly,
Malcolm Guiver,
Ferry Hagen,
Catriona Halliday,
Petr Hamal,
Werner Heinz,
Katia Jaton,
Elizabeth A. Johnson,
Brian Jones,
Lena Klingspor,
Rasmus Krøger Hare,
Michaela Lackner,
Katrien Lagrou,
Frédéric Lamoth,
Martina Lengerová,
Chris Linton,
Deborah Lockhart,
Johan Maertens,
Willem J. G. Melchers,
Carlo Mengoli,
Laurence Millon,
Oliver Morton,
Minh Hong Nguyen,
Lilyann Novak Frazer,
Melinda Paholcsek,
Tom W. Patterson,
Wilfried Posch,
Riina RautemaaRichardson,
Volker Rickerts,
Thomas R. Rogers,
Markus Ruhnke,
Boualem Sendid,
Eveline Snelders,
TimoleonAchilleas Vyzantiadis,
Peter Warn,
Adilia Warris,
Barbora Weinbergerová,
Birgit Willinger
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky325
Subject(s) - invasive candidiasis , antifungal , medicine , intensive care medicine , medical physics , dermatology , fluconazole
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom